Avanos supplements merger proxy statement due to shareholder lawsuits

Avanos Medical, Inc. is voluntarily supplementing its definitive proxy statement related to its proposed merger with A-AV Holdco I, Inc. This action follows two lawsuits and several demand letters from purported stockholders alleging disclosure deficiencies in the original proxy statement. While Avanos denies the allegations and believes no further disclosure is legally required, it is providing the supplements to avoid potential delays and minimize litigation risks. The company's board continues to unanimously recommend that stockholders vote "FOR" the merger at the Special Meeting on July 22, 2026.